Alex Wong | Getty Images
Amazon CEO Jeff Bezos, founder of space venture Blue Origin and owner of The Washington Post, participates in an event hosted by the Air Force Association September 19, 2018 in National Harbor, Maryland.
Some investors worry about what this will mean for drugstores and middlemen, like pharmacy benefit managers, as well as distributors.
The industry is in a state of flux, and that change will dominate the week. How drug companies can grow in a world where it’s getting harder to raise prices without igniting a Trump tweet. Pfizer CEO Ian Read delayed plans to increase prices on several drugs after Trump tweeted in July that “Pfizer and others should be ashamed that they have raised drug prices for no reason.”
How the once well-defined lines between sectors are blurring, especially now that CVS Health has closed its acquisition of Aetna and pharma giant Bristol-Myers Squibb last week announced plans to buy biotech behemoth Celgene.
What happens with the joint venture between J.P. Morgan, Berkshire Hathaway and Amazon, and whether other employers will try to lower health-care costs on their own.
Be the first to comment